| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |